Enliven Therapeutics, Inc. (ELVN) Net income 2019–2025
Enliven Therapeutics, Inc. (ELVN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$103.7MFY2025 · since FY2019: -$23.5M → -$103.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.7M | -16.5% |
| FY2024 | -$89.0M | -24.3% |
| FY2023 | -$71.6M | -90.1% |
| FY2022 | -$37.7M | -52.2% |
| FY2021 | -$24.7M | +40.2% |
| FY2020 | -$41.4M | -76.3% |
| FY2019 | -$23.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice